How To Manage Spondyloarthritis Long-Term With Biological DMARDs

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session on the long term use of biological DMARDs in managing spondyloarthritis. We have Dr Alakendu Ghosh as the chairperson, Dr. Fabian Proft Nikolai and Dr Bhowmik Meghnathi as the speakers in this session.

Spondyloarthritis is a type of arthritis where the spine is affected and, in some cases, the joints of the arms and legs are also affected. It can also involve the skin, intestines and eyes. The primary symptom observed in most patients is low back pain, mostly axial spondyloarthritis. 

It is thought that spondyloarthritis develops through the interaction of genetic and environmental factors. Further, spondyloarthropathies (SpA) is recognised as autoimmune disease as it is strongly associated with HLA-B27, a gene variant that controls immune responses. 

A disease-modifying anti- rheumatic drug (DMARD) can be used as medication for ankylosing spondylitis that may start soon after diagnosis . These drugs are called “anti-rheumatics” because these were primarily used for people with rheumatoid arthritis.

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars